p53 accumulation promotes dephosphorylation and proteolytic cleavage of retinoblastoma protein in human malignant glioma cells

Cellular Physiology and Biochemistry

Volumn 7, Issue 6, 1997, Pages 304-311

  Wagenknecht, Bettina ^a   Trepel, Martin ^a   Deimling, Andreas Von ^c   Grimmei, Cornelia ^a   Rollbrocke, Britta ^c   Hayash, Yutaka ^c   Lang, Florian ^b,c   Dichgans, Johannes ^a,c   Gulbins, Erich ^b,c   Weller, Michael ^a,c  

^a Department of Neurology   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Apoptosis; Chemotherapy; Malignant glioma; p53; RB protein

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; DEPHOSPHORYLATION; ENZYME ACTIVITY; GENE TRANSFER; GENOTOXICITY; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

MURINAE;

EID: 0030656196     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000154888     Document Type: Article

References (30)

1. Pickslcy SM. Lane DP: p53 and RB: Their cellular roles. Curr Opin Cell Biol 1994;6:853-858.
2. Clarke AR: Murine models of neoplasia: Functional analysis of the tumour suppressor genes RB-I and p53. Cancer Metast Rev 1995:14: 125-148.
3. Harvey M. Vogel H. Lee EYHP, Bradley A, Donehower LA: Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 1995:55:1146-1151.
4. Kouzaridcs T: Functions of pRband p53: What's the connection. Trends Cell Biol 1995:5:448-450.
5. Haupt Y. Rowan S. Oren M: p53-mediated apoptosis in Hela cells can be overcome by excess RB. Oncogene 1995:10:1563-1571.
6. Haas-Kogan DA. Kogan SC, Levi D. Dazin P. Tang A. Fung YKT. Israel MA: Inhibition of apoptosis by the retinoblastoma gene product. HMBOJ 1995;14:461-472.
7. Almasan A, Yin Y. Kelly RE. Lee EYH, Bradley A, Li W, Bertino JR. Wahl GM: Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 1995;92: 5436-5440.
8. Li W. Fan J, Hochhauscr D, Baner-jee D. Zielinski Z, Almasan A, Yin Y. Kelly R, Wahl GM. Bertino JR: Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proc Natl Acad Sci USA 1995;92:10436-10440.
9. Michalowitz D. Halevy O, Oren M: Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 1990:62:671-680.
10. Weller M, Frei K. Groscurth P. Krammcr PH. Yonekawa Y. Fontana A: Anti-Fas/APO-l antibody-mediated apoptosis of cultured human malignant glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 1994:94:954-964.
11. Weller M. Malipiero UV. Aguzzi A. Reed JC, Fontana A: Protooncogcne bcl-2 gene transfer abrogates Fas/ APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest 1995:95: 2633-2643.
12. Weller M. Malipiero U. Rensing-Ehl A. Barr P, Fontana A: Fas/APO-1 gene transfer for human malignant glioma. Cancer Res 1995:55:2936-2944.
13. Ryan JJ. Prochownik E, Gottlieb CA. Apel IJ. Merino R. Nunez G, Clarke MF: c-myc and bcl-2 modulate p53-function by altering p53 subccllular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994;91:5878-5882.
14. Weller M. Malipiero U, Groscurth P. Fontana A: T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-pi: Modulation by the phosphatase inhibitors. okadaic acid and calyculin A. Exp Cell Res 1995:221:395-403.
15. Rollbrocker B. Waha A. Louis DN, Wiestler O, von Dcimling A: Amplification of the cyclin-dcpendcnt kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme. Acta Neuro-patho! 1996:92:70-74.
16. Ueki K, Ono Y. Henson JW. Efird JT. Von Dcimling A. Louis DN: CDKN2/pl6 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 1996:56:150-153.
17. Trepcl M. Dichgans J, Malipiero U. Fontana A. Weller M: p53 gene transfer for malignant glioma: Influence on sensitivity to anticancer drugs. J Neurooncol 1996:30:95.
18. Xiao ZX. Chen J, Levine AJ. Modj-tahedi N. Xing J, Sellers WR. Livingston DM: Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 1995: 375:694-698.
19. Dou QP. Lui VWY: Failure to de-phosphorylate retinoblastoma protein in drug-resistant cells. Cancer Res 1995;55:5222-5225.
20. Roth W. Fontana A. Trepcl M. Dichgans J. Reed JC. Weller M: Im-munochemothcrapy of malignant glioma: Synergistic activity of CD95 ligand and chemotherapcutics. Cancer Immunol Immunother 1997:44: 55-63.
21. An B. Dou QP: Cleavage of retinoblastoma protein during apoptosis: An interleukin-ip-converting en-zvmc-like protease as a candidate. Cancer Res 1996;56:438-442.
22. INMor retinoblastoma protein (pRB). or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 1995:55:4833-4836.
23. Henson JW. Schnitker BL. Correa KM. Von Dcimling A. Fassbcnder F. Xu HJ. Benedict WF. Yandcll DW, Louis DN: The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994;36:714-721.
24. INKJexpression is frequent in high grade gliomas. Cancer Res 1995:55:1941-1945.
25. Schmidt EE, Ichimura K. Reifen-berger G. Collins VP: CDKN2 (pi6/ MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994:54: 6321-6324.
26. Srivenugopal K. Ali-Osntan F: Deletions and rearrangements inactivate the pl6INK4 gene in human glioma cells. Oncogene 1996; 12:2029-2034.
27. Costello JF. Berger MS. Huang HJS. Cavenee WK: Silencing of pi6/ cdkn2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 1996:56: 2405-2410.
28. Arap W, Nishikawa R. Fumari FB. Cavenee WK. Huang HJS: Replacement of the p!6/CDKN2 gene suppresses human glioma cell growth. Cancer Res 1995;55:1351-1354.
29. Van Meir EG. Kikuchi T. Tada M. Li H. Discrcns AC. Wojcik BE. Huang H, Friedmann T. de Tribolct N. Cavenee WK: Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 1994: 54:649-652.
30. Weller M. Trepcl M. Schabet M. Krajewski S. Reed JC: Hvpericin-based phototoxic proapoptotic pharmacotherapy of human malignant glioma. J Neurooncol 1996:30:106.